Amedisys Inc
Exchange: NASDAQSector: HealthcareIndustry: Medical Care Facilities
Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; home-based recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. Nearly 3,000 hospitals and more than 110,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 19,000 employees in 521 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of nearly 470,000 patients in need every year, performing more than 10.6 million visits annually.
Did you know?
Net income compounded at -15.6% annually over 6 years.
Current Price
$100.99
+0.01%GoodMoat Value
$205.64
103.6% undervaluedProfile
Valuation (TTM)
Market Cap$3.31B
P/E38.71
EV—
P/B2.92
Shares Out32.82M
P/Sales1.38
Revenue$2.40B
EV/EBITDA14.14
Amedisys Inc (AMED) Stock Analysis
Market Cap$3.31B
Current Price$100.99
P/E Ratio38.71
Forward P/E—
PEG Ratio-2.74
EPS$1.31
Book Value$34.57
P/B Ratio2.92
AMED Financial Charts
FCF vs CAPEX
FCFCAPEX
Forward estimates use -0.1% FCF growth (CAGR)
Cash vs Debt
Net Debt: 156M
Revenue
1.7B
FY18
2.0B
FY19
2.1B
FY20
2.2B
FY21
2.2B
FY22
2.2B
FY23
2.3B
FY24
Net Income
119M
FY18
127M
FY19
184M
FY20
209M
FY21
119M
FY22
—
FY23
43M
FY24
AMED 52-Week Range
$93.43
$100.99
50-Day MA: $97.76200-Day MA: —
Did you know?
AMED's revenue grew at a 5.9% CAGR over the last 6 years.
Amedisys Inc (AMED) Financial Summary
Amedisys Inc (AMED) is a Healthcare company in the Medical Care Facilities industry, listed on NASDAQ. The stock currently trades at $100.99 with a market capitalization of $3.31B.
Key valuation metrics include a P/E ratio of 38.71, price-to-book ratio of 2.92, and EPS of $1.31. The company reports a profit margin of 3.6% and return on equity of 7.5%.
AMED Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $3.31B |
| P/E Ratio | 38.71 |
| EPS | $1.31 |
| P/B Ratio | 2.92 |
| P/S Ratio | 1.38 |
| EV/EBITDA | 14.14 |
| Profit Margin | 3.6% |
| Return on Equity | 7.5% |
| Debt/Equity | 0.40 |
AMED Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY18 | $1.66B | $119.35M |
| FY19 | $1.96B | $126.83M |
| FY20 | $2.07B | $183.61M |
| FY21 | $2.21B | $209.07M |
| FY22 | $2.22B | $118.61M |
| FY23 | $2.24B | $-9.75M |
| FY24 | $2.35B | $43.23M |
Amedisys Inc (AMED) Valuation
Based on GoodMoat's DCF model, Amedisys Inc has a fair value estimate of $205.64. At the current price of $100.99, the stock appears 50.9% undervalued relative to our intrinsic value estimate.
AMED Quality Indicators
Amedisys Inc maintains a profit margin of 3.6% and an operating margin of 4.0%. Return on equity stands at 7.5%. The current ratio is 1.23. Debt-to-equity ratio is 0.40.
About Amedisys Inc
Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; home-based recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. Nearly 3,000 hospitals and more than 110,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 19,000 employees in 521 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of nearly 470,000 patients in need every year, performing more than 10.6 million visits annually.
AMED Free Cash Flow
Amedisys Inc generated $215.12M in trailing twelve-month free cash flow, representing an FCF yield of 6.49%. This strong FCF yield suggests the company generates substantial cash relative to its market value.
AMED Shares Outstanding
Amedisys Inc has 0.03 billion shares outstanding at a share price of $100.99, giving it a market capitalization of $3.31B.